Literature DB >> 4644642

An overview of the analysis and interpretation of bioavailability studies in man.

J G Wagner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4644642     DOI： 10.1159/000136328

Source DB:  PubMed          Journal:  Pharmacology        ISSN： 0031-7012            Impact factor:   2.547


× No keyword cloud information.
  7 in total

1.  Physiological modeling to understand the impact of enzymes and transporters on drug and metabolite data and bioavailability estimates.

Authors:  Huadong Sun; K Sandy Pang
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

2.  Suitability of various noninfinity area under the plasma concentration-time curve (AUC) estimates for use in bioequivalence determinations: relationship to AUC from zero to time infinity (AUC0-INF).

Authors:  M N Martinez; A J Jackson
Journal:  Pharm Res       Date:  1991-04       Impact factor: 4.200

3.  Bioavailability assessment: methods to estimate total area (AUC O to infinity) and total amount excreted (A infinity e) and importance of blood and urine sampling scheme with application to digoxin.

Authors:  J G Wagner; J W Ayres
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

4.  Comparative human oral clinical pharmacology of cefadroxil, cephalexin, and cephradine.

Authors:  M Pfeffer; A Jackson; J Ximenes; J P de Menezes
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

5.  Pharmacokinetics of ketoprofen following single oral, intramuscular and rectal doses and after repeated oral administration.

Authors:  T Ishizaki; T Sasaki; T Suganuma; Y Horai; K Chiba; M Watanabe; W Asuke; H Hoshi
Journal:  Eur J Clin Pharmacol       Date:  1980-11       Impact factor: 2.953

6.  Comparative pharmacokinetics of cephalexin, cefaclor, cefadroxil, and CGP 9000.

Authors:  H Lode; R Stahlmann; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

7.  [Pharmacokinetics of cefaclor and initial therapeutical experience (author's transl)].

Authors:  H Lode; P Köppe; R Stahlmann
Journal:  Infection       Date:  1979       Impact factor: 3.553
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.